GB201603263D0 - Biomarkers for response to bip (rasolvir) - Google Patents

Biomarkers for response to bip (rasolvir)

Info

Publication number
GB201603263D0
GB201603263D0 GBGB1603263.3A GB201603263A GB201603263D0 GB 201603263 D0 GB201603263 D0 GB 201603263D0 GB 201603263 A GB201603263 A GB 201603263A GB 201603263 D0 GB201603263 D0 GB 201603263D0
Authority
GB
United Kingdom
Prior art keywords
rasolvir
bip
biomarkers
response
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB1603263.3A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Kings College London
Original Assignee
Kings College London
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kings College London filed Critical Kings College London
Priority to GBGB1603263.3A priority Critical patent/GB201603263D0/en
Publication of GB201603263D0 publication Critical patent/GB201603263D0/en
Priority to PCT/GB2017/050486 priority patent/WO2017144897A1/en
Ceased legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/564—Immunoassay; Biospecific binding assay; Materials therefor for pre-existing immune complex or autoimmune disease, i.e. systemic lupus erythematosus, rheumatoid arthritis, multiple sclerosis, rheumatoid factors or complement components C1-C9
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/46—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates
    • G01N2333/47—Assays involving proteins of known structure or function as defined in the subgroups
    • G01N2333/4701—Details
    • G01N2333/4737—C-reactive protein
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/475—Assays involving growth factors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/52—Assays involving cytokines
    • G01N2333/54—Interleukins [IL]
    • G01N2333/5421—IL-8
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/10—Musculoskeletal or connective tissue disorders
    • G01N2800/101—Diffuse connective tissue disease, e.g. Sjögren, Wegener's granulomatosis
    • G01N2800/102—Arthritis; Rheumatoid arthritis, i.e. inflammation of peripheral joints
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Urology & Nephrology (AREA)
  • Physics & Mathematics (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Biotechnology (AREA)
  • Rheumatology (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Rehabilitation Therapy (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Microbiology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
GBGB1603263.3A 2016-02-25 2016-02-25 Biomarkers for response to bip (rasolvir) Ceased GB201603263D0 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
GBGB1603263.3A GB201603263D0 (en) 2016-02-25 2016-02-25 Biomarkers for response to bip (rasolvir)
PCT/GB2017/050486 WO2017144897A1 (en) 2016-02-25 2017-02-24 Biomarkers for response to bip (rasolvir™)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB1603263.3A GB201603263D0 (en) 2016-02-25 2016-02-25 Biomarkers for response to bip (rasolvir)

Publications (1)

Publication Number Publication Date
GB201603263D0 true GB201603263D0 (en) 2016-04-13

Family

ID=55806916

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB1603263.3A Ceased GB201603263D0 (en) 2016-02-25 2016-02-25 Biomarkers for response to bip (rasolvir)

Country Status (2)

Country Link
GB (1) GB201603263D0 (en)
WO (1) WO2017144897A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2023187422A1 (en) * 2022-03-31 2023-10-05 Revolo Biotherapeutics Limited Compositions and their use in methods for treating intestinal inflammation

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2344327A1 (en) 1998-09-14 2000-04-13 The Trustees Of Columbia University Superconducting resonator and filter devices and methods for manufacturing same
GB9822115D0 (en) 1998-10-09 1998-12-02 King S College London Treatment of inflammatory disease
ES2525096T3 (en) 2005-04-19 2014-12-17 Kings College London Use of beep against bone loss and osteoporosis
US20080155704A1 (en) 2006-12-22 2008-06-26 King's College London Methods and Compositions for Determining in vivo Activity of BiP

Also Published As

Publication number Publication date
WO2017144897A1 (en) 2017-08-31

Similar Documents

Publication Publication Date Title
HK1258539A1 (en) Micro-moment analysis
HK1257760A1 (en) Multispecific antibodies
GB2554180B (en) Spectrometric analysis
GB2602212B (en) Spectrometric analysis
HK1254352A1 (en) Affinity chromatography devices
SG10202007262PA (en) Copanlisib biomarkers
GB201521751D0 (en) Novel uses
SG10202007322PA (en) Copanlisib biomarkers
GB201614455D0 (en) Biomarkers
GB201417341D0 (en) Chromatography
PT3364189T (en) Immunochromatographic test piece
KR101581877B9 (en) Assembly block set
GB201404189D0 (en) Novel biomarkers
EP3269808A4 (en) Improved beta-fructofuranosidase
GB201500729D0 (en) Novel Biomarkers
EP3303637A4 (en) Sample to sequence
PT3391016T (en) Sampler
GB201512133D0 (en) Biomarkers
GB201511951D0 (en) An eyeguard
GB201603263D0 (en) Biomarkers for response to bip (rasolvir)
GB2550166B (en) Improvements to letter-plates
GB201702767D0 (en) Title not available
GB201516841D0 (en) Novel biomarker
GB201521446D0 (en) Biomarker
GB201519704D0 (en) Biomarkers

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)